ASP1948
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Conditions
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Trial Timeline
Oct 30, 2019 → Feb 2, 2022
NCT ID
NCT04094506About ASP1948
ASP1948 is a phase 1 stage product being developed by Astellas Pharma for Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies. The current trial status is completed. This product is registered under clinical trial identifier NCT04094506. Target conditions include Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies.
What happened to similar drugs?
5 of 20 similar drugs in Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies were approved
Approved (5) Terminated (1) Active (14)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04094506 | Phase 1 | Completed |
Competing Products
20 competing products in Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies